Epidermolysis Bullosa Acquisita Treated with Basiliximab, an Interleukin-2 Receptor Antibody

Author: Haufs Michael G.   Haneke Eckart  

Publisher: Medical Journals Limited

ISSN: 0001-5555

Source: Acta Dermato-Venereologica, Vol.81, Iss.1, 2001-01, pp. : 72-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content